Growth Behavior and Implications for Staging and Therapy

  • D. von Fournier
Conference paper


In accordance with the concept of breast cancer as a primarily loco-regional disease, a type of therapy was developed that quickly became linked with the names of Halsted (1894), Steinthal (1905) and, in the German-speaking countries, Rotter (1896), and was accepted throughout the world for many years.


Breast Cancer Adjuvant Chemotherapy Breast Carcinoma Doubling Time Premenopausal Woman 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andersen JA, Nielsen M, Jensen J (1985) Essential histological findings in the female breast at autopsy. In: Zander J, Baltzer J (eds) Early breast cancer. Springer, Berlin Heidelberg New York, pp 52–63CrossRefGoogle Scholar
  2. 2.
    Boice J et al. (1988) Radiation dose and second cancer risk in patients treated for cancer of the cervix. JNCI: -Google Scholar
  3. 3.
    Bonadonna D, Valagussa P, Rossi A (1985a) Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95–115PubMedCrossRefGoogle Scholar
  4. 4.
    Bonadonna G, Rossi A, Valagussa P (1985b) Adjuvant CMF chemotherapy in operable breast cancer. Ten years later. World J Surg 9: 707–713PubMedCrossRefGoogle Scholar
  5. 5.
    Brinkley D, Haybittle JL (1977) The curability of breast cancer. World J Surg 1: 287PubMedCrossRefGoogle Scholar
  6. 6.
    Brinkley D, Haybittle JL (1984) Long-term survival of women with breast cancer. Lancet 1: 1118PubMedCrossRefGoogle Scholar
  7. 7.
    Bryant A J, Weir JA (1981) Prophylactic oophorectomy in operable instances of car-cinoma of the breast. Surg Gynecol Obstet 153: 660–664PubMedGoogle Scholar
  8. 8.
    Cole MP (1975) A clinical trial of an artificial menopause in carcinoma of the breast. Inserm 55: 143–150Google Scholar
  9. 9.
    Collins V, Loeffler RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol 76: 988–1000Google Scholar
  10. 10.
    De Moulin D (1983) A short history of breast cancer. Martinus Nijhoff, Boston, p 86Google Scholar
  11. 11.
    Duncan W, Kerr GR (1976) The curability of breast cancer. Br Med J IV: 781Google Scholar
  12. 12.
    Fisher B, Slack N, Katrych D (1975) Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140: 528–534PubMedGoogle Scholar
  13. 13.
    Fisher B, Redmond C, Fisher ER (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674PubMedCrossRefGoogle Scholar
  14. 14.
    Fisher E (1985) What is early breast cancer? In: Zander J, Baltzer J (eds) Early breast cancer. Springer, Berlin Heidelberg New York, pp 1–13CrossRefGoogle Scholar
  15. 15.
    Fournier D von, Hoeffken W, Junkermann H, Bauer M, Kiihn W (1985) Growth rate of primary mammary carcinoma and its metastases: consequences for early detection and therapy. In: Zander J, Baltzer J (eds) Early breast cancer. Springer, Berlin Heidelberg New York, pp 73–86CrossRefGoogle Scholar
  16. 16.
    Gershon-Cohen J, Berger SM, Klickstein HS (1963) Roentgenography of breast cancer moderating concept of “biological predeterminism.” Cancer 16: 961–964Google Scholar
  17. 17.
    Haagensen CD (1971) Diseases of the breast. Saunders, PhiladelphiaGoogle Scholar
  18. 18.
    Haagensen CD (1986) Diseases of the breast, 3rd edn. Saunders, PhiladelphiaGoogle Scholar
  19. 19.
    Halsted WS (1907) The results of radical operations for the cure of cancer of the breast. Ann Surg 46: 1–19PubMedCrossRefGoogle Scholar
  20. 20.
    Hayward JL (1985) Trials of wide excision and radiation therapy at the Breast Unit, Guy’s Hospital, London. In: Zander J, Baltzer J (eds) Early breast cancer. Springer, Berlin Heidelberg New York, pp 253–263CrossRefGoogle Scholar
  21. 21.
    Henderson IC, Canellos G (1980) Cancer of the breast: the past decade. N Engl J Med 302: 17, 79Google Scholar
  22. 22.
    Koscielny S, Tubiana M, Le MG (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49: 709–715PubMedCrossRefGoogle Scholar
  23. 23.
    Kusama S, Spratt JS, Donegan WL (1972) The gross rates of growth of human mammary carcinoma. Cancer 30: 594–599PubMedCrossRefGoogle Scholar
  24. 24.
    Lewis D, Rienhoff WF (1932) A study of results - John Hopkins Hospital 1889–1931. Ann Surg 25: 336CrossRefGoogle Scholar
  25. 25.
    Lundgren B (1983) The growth rate of breast cancer as a dynamic indicator of prognosis. Australas Radiol 27: 178–180PubMedCrossRefGoogle Scholar
  26. 26.
    Meakin JW, Allt WEC, Beale FA (1983) Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. Breast Cancer Res Treat [Suppl] 3: 45–48CrossRefGoogle Scholar
  27. 27.
    Meyer JS, Prey MU, Babcock DS, McDivitt RW (1986) Breast carcinoma cell kinetics, morphology, stage and host characteristics: a thymidine labeling study. Lab Invest 54: 41 - 51PubMedGoogle Scholar
  28. 28.
    Meyer W (1894) An improved method of the radical operation for carcinoma of the breast. Med Red 46: 745Google Scholar
  29. 29.
    Meyer W (1905) Carcinoma of the breast: 10-year experience with my method of radical operation. JAMA 45: 297Google Scholar
  30. 30.
    Nissen-Meyer R, Kjellgren K (1986) Perioperative adjuvant chemotherapy of breast cancer: the Scandinavian experience. Recent Results Cancer Res 00: 00 - 00Google Scholar
  31. 31.
    Nissen-Meyer R, Kjellgren K, Manssen R (1982) Adjuvant chemotherapy in breast cancer. Recent Results Cancer Res 80: 142–148PubMedGoogle Scholar
  32. 32.
    Nissen-Meyer R, Host H, Kjellgren K (1984) Scandinavian trials with one single post-operative course vs 12 courses. Recent Results Cancer Res 96: 48–54PubMedGoogle Scholar
  33. 33.
    Oeser H (1974) Krebsbekämpfung: Hoffnung und Realität. Thieme, Stuttgart, pp 12–39Google Scholar
  34. 34.
    Pearlman AW (1976) Breast cancer — influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrences. Cancer 38: 1826PubMedCrossRefGoogle Scholar
  35. 35.
    Powles TJ (1988) Advanced breast cancer — new approaches to treatment. A review. Eur J Cancer Cl in OncolGoogle Scholar
  36. 36.
    Rotter J (1896) Günstigere Dauererfolge durch ein verbessertes Operationsverfahren der Mammakarzinome. Berl Klin Wochenschr 33: 69–99Google Scholar
  37. 37.
    Silvestrini R, Diadone MG, Gasparini G (1985) Cell kinetics as a persistent prognostic marker in node-negative breast cancer. Cancer 56: 1982–1987PubMedCrossRefGoogle Scholar
  38. 38.
    Spratt JS, Spratt JA (1979) Growth rates. In: Donegan WL, Spratt JS ( 1979 ) Cancer of the breast. Saunders, Philadelphia, pp 197–221Google Scholar
  39. 39.
    Spratt JS, Kaltenbach ML, Spratt JA (1977) Cytokinetic definition of acute and chronic breast cancer. Cancer Res 37: 226PubMedGoogle Scholar
  40. 40.
    Spratt SS, Spratt JA (1985) What is breast cancer before we can detect it? J Surg Oncol 30: 156–160PubMedCrossRefGoogle Scholar
  41. 41.
    Steinthal CF (1905) Zur Dauerheilung des Brustkrebses. Beitr Klin Chir 47: 226Google Scholar
  42. 42.
    Tubiana M, Koscielny S (1988) Cell kinetics, growth rate and the natural history of breast cancer. The Heuson Memorial Lecture. Eur J Cancer Clin Oncol 24: 9–14PubMedCrossRefGoogle Scholar
  43. 43.
    Tubiana M, Malaise EP (1976) Comparison of cell proliferation kinetics in human and experimental tumors: response to irradiation. Cancer Treat Rep 60: 1887–1895PubMedGoogle Scholar
  44. 44.
    Tubiana M, Malaise EP (1984) Growth rate and cell kinetics in human tumors. In: Symington T, Carter RL (eds) On scientific functions of oncology. Year Book Medical, Chicago, pp 126–136Google Scholar
  45. 45.
    Tubiana M, Pejovic MH, Chavaudra N et al. (1984) The long term prognostic significance of the thymidine labeling index in breast cancer. Int J Cancer 33: 441–445PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. von Fournier

There are no affiliations available

Personalised recommendations